It's pretty wild that over its decade-long life, Hearthstone hasn't done any major crossovers with other Blizzard games. Obviously it's based on the Warcraft universe, but given the liberties ...

Charlie Hall is Polygon’s tabletop editor. In 12-plus years as a journalist & photographer, he has covered simulation, strategy, and spacefaring games, as well as public policy. StarCraft, the ...

Also with great fanfare, Florida Gov. Ron DeSantis announced in 2021 that Terran Orbital would invest $300 million in Florida to construct the world’s largest, state-of-the-art, commercial spacecraft ...

After a packed schedule of art openings and parties early in the week, the big day has arrived. Art Basel Hong Kong opened its doors to VIPs on Wednesday at the Convention and Exhibition Centre.

Und ehe man sich versieht, sind Jung und Alt darin vertieft ... 25 Abs. 1 TDDDG sowie Art. 6 Abs. 1 lit. a DSGVO durch uns und unsere bis zu Partner zu. Darüber hinaus nehmen Sie Kenntnis ...

The Art Basel and UBS Global Art Market Report 2025 by Arts Economics highlights an industry that, despite a decline in total sales value, remains dynamic and evolving. What factors shaped these ...

This exhibition features treasures from the Albertina Museum’s own holdings that impressively document the Alt family painters’ great importance in the context of 19th-century art, and is currently on ...

Kevan Staples, who was the co-founder of legendary 1970s alt rock band Rough Trade from Toronto, died on Sunday at the age of 74. His death was announced in a social media post by band co-founder ...

Staples co-wrote the band's risque breakout hit High School Confidential, as well the songs Birds of a Feather and All Touch. His death was announced in a social media post by band co-founder ...

25 Abs. 1 TDDDG sowie Art. 6 Abs. 1 lit. a DSGVO durch uns und unsere bis zu Partner zu. Darüber hinaus nehmen Sie Kenntnis davon, dass mit ihrer Einwilligung ihre Daten auch in Staaten ...

March 03, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate ...